These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 16207199

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Febrile pancytopenia associated with clopidogrel.
    Andres E, Perrin AE, Alt M, Goichot B, Schlienger JL.
    Arch Intern Med; 2001 Jan 08; 161(1):125. PubMed ID: 11146710
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Toxic skin reaction to clopidogrel].
    El-Majjaoui S, Tournillac I, Pinzani V, Dandurand M, Guillot B.
    J Mal Vasc; 2001 Jun 08; 26(3):207-8. PubMed ID: 11431626
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fixed drug eruption from ticlopidine, with positive lesional patch test.
    García CM, Carmena R, García R, Berges P, Camacho E, Cotter MP, de la Hoz B.
    Contact Dermatitis; 2001 Jan 08; 44(1):40-1. PubMed ID: 11156015
    [No Abstract] [Full Text] [Related]

  • 8. Nonfatal aplastic anemia associated with clopidogrel.
    Uz O, Kardeşoğlu E, Aparci M, Yiğiner O, Işilak Z, Ozmen N.
    Anadolu Kardiyol Derg; 2010 Jun 08; 10(3):291. PubMed ID: 20538571
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
    Storey RF, Husted S, Harrington RA, Heptinstall S, Wilcox RG, Peters G, Wickens M, Emanuelsson H, Gurbel P, Grande P, Cannon CP.
    J Am Coll Cardiol; 2007 Nov 06; 50(19):1852-6. PubMed ID: 17980251
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Febrile toxiderma in children].
    Larrègue M, Vabres P, Auriol F.
    Rev Prat; 1997 Sep 01; 47(13):1452-7. PubMed ID: 9339026
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.
    Cannon CP, Husted S, Harrington RA, Scirica BM, Emanuelsson H, Peters G, Storey RF, DISPERSE-2 Investigators.
    J Am Coll Cardiol; 2007 Nov 06; 50(19):1844-51. PubMed ID: 17980250
    [Abstract] [Full Text] [Related]

  • 19. [Long-term effect of clopidogrel do exist--but hardly worth the costs].
    Hansen O.
    Lakartidningen; 2003 Oct 09; 100(41):3216-7. PubMed ID: 14587263
    [No Abstract] [Full Text] [Related]

  • 20. Spontaneous abdominal hematoma in a patient treated with clopidogrel and aspirin.
    Otrock ZK, Sawaya JI, Zebian RC, Taher AT.
    Ann Hematol; 2006 Oct 09; 85(10):743-4. PubMed ID: 16821017
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.